Abstract
ObjectivesCholangiocarcinoma (CCA) is a heterogeneous malignancy with high mortality and dismal prognosis, and an urgent clinical need for new therapies. Knowledge of the CCA epigenome is largely limited to aberrant...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have